Journal Basic Info

  • Impact Factor: 1.809**
  • H-Index: 6
  • ISSN: 2474-1655
  • DOI: 10.25107/2474-1655
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Geriatric Medicine
  •  Orthopedic Surgery
  •  Chronic Disease
  •  Gastroenterology
  •  Vascular Medicine
  •  Cardiac Surgery
  •  Pediatrics
  •  Signs and Symptoms-Clinical Findings

Abstract

Citation: Ann Clin Case Rep. 2022;7(1):2138.DOI: 10.25107/2474-1655.2138

Unusual Metastatic Localizations of Urothelial Carcinoma of Ureter in Young Male Patient

Maria Giuseppa Vitale*, Marco Oltrecolli, Stefania Pipitone, Eleonora Molinaro, Cinzia Baldessari, Roberto Sabbatini, Massimo Dominici and Cecilia Nasso

Department of Oncology and Hematology, Modena University Hospital, Italy

*Correspondance to: Maria Giuseppa Vitale 

 PDF  Full Text Case Report | Open Access

Abstract:

Renal pelvis and ureter‘s tumors constitute upper urinary tract tumors, whose histological subtype is urothelial carcinoma, that occurs more frequently in bladder. The pattern of metastases is similar between upper urinary tract and bladder urothelial carcinoma: Lymph nodes, liver, bone and lung. Here we describe a case report where a 43-years-old man affected by urothelial carcinoma of ureter underwent right nephroureterectomy and retroperitoneal lymph nodes dissection and then it was administered adjuvant chemotherapy (4 cycles of cisplatin/gemcitabine). Then, during his clinical and radiological follow-up, some uncommon sites of metastases were found, such as stomach, peritoneum, left axillary, right and left supraclavicular lymph node. At the end of five cycles of first-line chemotherapy, he developed symptoms connected to Leptomeningeal Carcinomatosis (LMC), which is absolutely an atypical site of relapse for this kind of tumor. Patient was treated with intrathecal methotrexate 12 mg once weekly and second-line therapy with Pembrolizumab 200 mg flat dose for four cycles. In literature we have found only other two case reports which describe LMC in urothelial carcinoma of upper urinary tract and no patient affected by this tumor treated with systemic immunotherapy and intrathecal chemotherapy for LMC. Our patient died three months after the LMC diagnosis, supporting the fact that the prognosis for this site of metastasis is poor.

Keywords:

Urothelial carcinoma; Leptomeningeal carcinomatosis; Metastatic

Cite the Article:

Vitale MG, Oltrecolli M, Pipitone S, Molinaro E, Baldessari C, Sabbatini R, et al. Unusual Metastatic Localizations of Urothelial Carcinoma of Ureter in Young Male Patient. Ann Clin Case Rep. 2022; 7: 2138..

Search Our Journal

Journal Indexed In

Articles in PubMed

Tocotrienols: Exciting Biological and Pharmacological Properties of Tocotrienols and other Naturally Occurring Compounds, Part I
 PubMed  PMC  PDF  Full Text
A New Minimally Invasive Procedure for Muscle, Back, Neck Pain and Radiculopathy - The Myofascial Nerve Block
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Are Older Women More Susceptible to Dress Syndrome? A Case Series and Literature Review
 Abstract  PDF  Full Text
Thyroid Hormone Resistance Syndrome Caused by Heterozygous R338W Mutation in Thyroid Hormone Receptor β: Report of one Chinese Pedigree a in Southwest China
 Abstract  PDF  Full Text
View More...